Abstract
A series of [(p-cymene)Ru(TSC)Cl]Cl compounds ([1]Cl, [2]Cl and [3]Cl) and their corresponding [(p-cymene)Ru(TSC)Cl][(p-cymene)RuCl3] derivatives ([1][(p-cymene)RuCl3], [2][(p-cymene)RuCl3] and [3][(p-cymene)RuCl3]) have been synthesized and characterized by H1 NMR, elemental analysis and HR-ESI-mass spectrometry. The molecular structures of [2]Cl, [3]Cl, [1][(p-cymene)RuCl3], [2][(p-cymene)RuCl3] and [3][(p-cymene)RuCl3] have been characterized by single-crystal X-ray diffraction analysis. The complexes have been further evaluated for their in vitro antiproliferative activities against the SGC-7901 human gastric cancer, BEL-7404 human liver cancer and HEK-293T noncancerous cell lines. Furthermore, the interactions of the complexes [1]Cl and [1][(p-cymene)RuCl3] with HSA have been followed by fluorescence spectrometry studies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
